Author
Listed:
- Trista E. North
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA)
- Wolfram Goessling
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA)
- Carl R. Walkley
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA)
- Claudia Lengerke
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA)
- Kamden R. Kopani
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA)
- Allegra M. Lord
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA)
- Gerhard J. Weber
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA)
- Teresa V. Bowman
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA)
- Il-Ho Jang
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA)
- Tilo Grosser
(Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA)
- Garret A. FitzGerald
(Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA)
- George Q. Daley
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA)
- Stuart H. Orkin
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA
Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA)
- Leonard I. Zon
(Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA)
Abstract
A tonic to the blood A previously unidentified modulator of vertebrate haematopoietic stem cell (HSC) number has been discovered using a chemical genetic screen in zebrafish. Prostaglandin E2 (PGE2) increases HSCs in the embryo and enhances marrow recovery following irradiation of adult fish. These effects of PGE2 on stem and progenitor cell number are conserved across vertebrate species. This suggests that modulation of this pathway could be used to treat patients undergoing bone marrow transplant and for some forms of anaemia.
Suggested Citation
Trista E. North & Wolfram Goessling & Carl R. Walkley & Claudia Lengerke & Kamden R. Kopani & Allegra M. Lord & Gerhard J. Weber & Teresa V. Bowman & Il-Ho Jang & Tilo Grosser & Garret A. FitzGerald &, 2007.
"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis,"
Nature, Nature, vol. 447(7147), pages 1007-1011, June.
Handle:
RePEc:nat:nature:v:447:y:2007:i:7147:d:10.1038_nature05883
DOI: 10.1038/nature05883
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Trent D. Hall & Hyunjin Kim & Mahmoud Dabbah & Jacquelyn A. Myers & Jeremy Chase Crawford & Antonio Morales-Hernandez & Claire E. Caprio & Pramika Sriram & Emilia Kooienga & Marta Derecka & Esther A. , 2022.
"Murine fetal bone marrow does not support functional hematopoietic stem and progenitor cells until birth,"
Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Xiaoyi Cheng & Radwa Barakat & Giulia Pavani & Masuma Khatun Usha & Rodolfo Calderon & Elizabeth Snella & Abigail Gorden & Yudi Zhang & Paul Gadue & Deborah L. French & Karin S. Dorman & Antonella Fid, 2023.
"Nod1-dependent NF-kB activation initiates hematopoietic stem cell specification in response to small Rho GTPases,"
Nature Communications, Nature, vol. 14(1), pages 1-19, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:447:y:2007:i:7147:d:10.1038_nature05883. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.